These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6224127)

  • 41. [Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
    Piérard GE
    Rev Med Liege; 1997 Feb; 52(2):120-2. PubMed ID: 9173479
    [No Abstract]   [Full Text] [Related]  

  • 42. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
    Eichenfield L
    Cutis; 2009 Nov; 84(5 Suppl):3-4. PubMed ID: 19999186
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
    Biswas S; Mondal KK; Dutta RN; Sarkar DK
    J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acne vulgaris.
    Purdy S
    Clin Evid; 2005 Jun; (13):2038-59. PubMed ID: 16135322
    [No Abstract]   [Full Text] [Related]  

  • 45. The BEST study: results according to prior treatment.
    Rodriguez D; Davis MW
    Cutis; 2003 Feb; 71(2 Suppl):27-34. PubMed ID: 12630672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibiotics, azelaic acid and benzoyl peroxide in topical acne therapy].
    Fluhr JW; Degitz K
    J Dtsch Dermatol Ges; 2010 Mar; 8 Suppl 1():S24-30. PubMed ID: 20482689
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris.
    Chalker DK; Shalita A; Smith JG; Swann RW
    J Am Acad Dermatol; 1983 Dec; 9(6):933-6. PubMed ID: 6227643
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of vehicle formulation on acne medication tolerability.
    Draelos ZD; Callender V; Young C; Dhawan SS
    Cutis; 2008 Oct; 82(4):281-4. PubMed ID: 19055172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential role for a new combination topical therapy in treating mild to moderate acne vulgaris.
    Tschen E
    Cutis; 2001 Feb; 67(2 Suppl):25-7. PubMed ID: 11236212
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
    Zeichner JA; Wong V; Linkner RV; Haddican M
    J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current topical acne therapy (continuing education).
    Popovich NG; Sperandio GJ
    J Pract Nurs; 1985 Jun; 35(2):23-31. PubMed ID: 3159886
    [No Abstract]   [Full Text] [Related]  

  • 53. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
    Ceilley RI
    Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clindamycin/benzoyl peroxide gel (BenzaClin): a review of its use in the management of acne.
    McKeage K; Keating GM
    Am J Clin Dermatol; 2008; 9(3):193-204. PubMed ID: 18429651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A clinical trial comparing the safety and efficacy of a topical erythromycin-zinc formulation with a topical clindamycin formulation.
    Sweren RJ
    J Am Acad Dermatol; 1991 Apr; 24(4):664-5. PubMed ID: 1827802
    [No Abstract]   [Full Text] [Related]  

  • 56. Implications of the BEST study.
    Shavin J; Weiss J
    Cutis; 2003 Feb; 71(2 Suppl):35-6. PubMed ID: 12630673
    [No Abstract]   [Full Text] [Related]  

  • 57. [Acne and its drug treatment].
    Büchner SA
    Ther Umsch; 1990 Aug; 47(8):670-4. PubMed ID: 2145653
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acne: current concepts of pathogenesis and approach to rational treatment.
    Eichenfield LF; Leyden JJ
    Pediatrician; 1991; 18(3):218-23. PubMed ID: 1835004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Management of acne vulgaris: focus on clindamycin and zinc].
    Korting HC; Schöllmann C
    Hautarzt; 2009 Jan; 60(1):42-7. PubMed ID: 19082570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The extinction of topical erythromycin therapy for acne vulgaris and concern for the future of topical clindamycin.
    Austin BA; Fleischer AB
    J Dermatolog Treat; 2017 Mar; 28(2):145-148. PubMed ID: 27425633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.